A 10-year follow-up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision-making in terms of treatments and side effects for a diverse population. The CEASAR (Comparative Effectiveness Analysis of Surgery and Radiation for Localized Prostate Cancer) study, coordinated by VUMC, is a multisite research study conducting long-term follow-up on men who were diagnosed with localized prostate cancer between 2011 and 2012.

Human research will be more equitable, inclusive and stronger if the people who are participants in studies also help plan and guide the direction of those studies.

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center's research programs.

Computed tomography scans for people at risk for lung cancer lead to earlier diagnoses and improve survival rates, but they can also lead to overtreatment when suspicious nodules turn out to be benign.

A study by Vanderbilt researchers has identified genomic alterations in early stage adenocarcinomas of the lung that may indicate whether the lesions develop into aggressive tumors.

A five-year follow-up study of U.S. men who received prostate cancer treatment is creating a road map for future patients to clarify expectations and enable men to make informed choices about care.

Travis Osterman, DO, MS, has been awarded a Microsoft Investigator Fellowship.

A new multisite study will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

Shari Barkin, MD, MSHS, division chief of General Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt, was honored recently with the 2019 Academic Pediatric Association (APA) Research Award.

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery, according to interim results of a recent study.